Journal article

Intravenous bevacizumab causes regression of choroidal neovascularization secondary to diseases other than age-related macular degeneration

Quan Dong Nguyen, Syed Mahmood Shah, Gulnar Hafiz, Diana V Do, Julia A Haller, Roberto Pili, Ingrid E Zimmer-Galler, Kashif Janjua, RC Andrew Symons, Peter A Campochiaro

American Journal of Ophthalmology | ELSEVIER SCIENCE INC | Published : 2008

DOI: 10.1016/j.ajo.2007.09.025

Grants

Awarded by NATIONAL CANCER INSTITUTE

Awarded by NATIONAL EYE INSTITUTE

Awarded by NCI NIH HHS

Awarded by NEI NIH HHS

Citation metrics

23Web of Science
29Scopus

Keywords

Intravitreal Bevacizumab
Capillary Permeability
Myopia, Degenerative
Life Sciences & Biomedicine
Science & Technology
Ophthalmology
Growth-Factor
Visual Acuity
Male
Choroidal Neovascularization
Ranibizumab
Tomography, Optical Coherence
Vascular Endothelial Growth Factor a
Bevacizumab
Adult
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Middle Aged
Membranes
Angiogenesis Inhibitors
Infusions, Intravenous
Female
Humans
Retinal Diseases
Avastin
Fluorescein Angiography